Likewise, neuropeptide Y also inhibits cardiac adenylate cyclase [437] and the combination of high leptin, peptide YY and neuropeptide Y together with low ghrelin has in the hemodialysis population been linked to hypertension, inadequate vasodilation and cardiac hypertrophy and hence could predispose to cardiovascular events [438]. Here, NPY is linked to cardiac hypertrophy.